Clinical trial NCT06013982: Stroke and Anxiety Reduction
Official title: Impact of a Structured Anxiety Reduction Program on Anxiety in Patients Who Are Discharged to Home Following an Acute Stroke in an Academic Medical Center
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Acute Stroke
Lead sponsor: NYU Langone Health
Sponsor class: OTHER
First posted: 2023-08-28
Enrollment: 34
Sex: ALL
Minimum age (years): 18
Maximum age (years): 89
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: SUPPORTIVE_CARE

Brief summary: The purpose of this pilot study is to explore the impact that a structured anxiety reduction intervention program has on patients being discharged to home following an acute stroke in an academic medical center. Eligible participants will be screened and recruited by the research team through daily rounds. After completing the informed consent process, the research team will pull demographic information from the electronic health record (EHR) and REDCAP that includes ethnicity and support system. Participants will complete the Anxiety Screen Questionnaire (GAD-7 ANXIETY SURVEY) and will be provided with information regarding stroke support groups available with additional NYU Langone Health and the American Heart Association internet-based information regarding anxiety reduction (NYU Langone Health Anxiety Reduction Bundle). The participants will be encouraged to attend a stroke support group for 3 months and utilize the NYU Langone Health Anxiety Reduction Bundle provided. At the completion of the intervention (3 months), participants will be provided with the GAD-7 ANXIETY SURVEY again and a survey that includes open-ended questions and a program evaluation by email. Analysis will occur after final data is collected.


Eligibility criteria: Inclusion Criteria:

* Be diagnosed with an acute stroke
* Able to speak, read and write in English
* Not cognitively impaired, as per standard of care documentation in the EHR regarding mental status.
* Discharged to home
* Internet access including email
* Willingness to participate in an anxiety reduction program
* Length of hospital stay less than 5 days from the initial presentation of stroke symptoms
* Must be medically stable

Exclusion Criteria:

* Not diagnosed with an acute stroke
* Unable to speak, read and write in English as this intervention is not available in other languages and at this time, funding is not available in order to have the resources provided translated or to have translation services available for these participants.
* Not discharged to home
* No internet access including email
* Unwilling or unable to participate in an anxiety reduction program
* Cognitively impaired
* Length of hospital stay greater than 6 days from the initial presentation of stroke symptoms
* Not medically stable

Primary outcomes:
measure: Change in GAD-7 Score from Baseline to Month 3
timeFrame: Baseline, Month 3
Secondary outcomes:
Other outcomes:
Locations:
city: New York
country: United States
facility: NYU Langone Health
state: New York
Study officials:
affiliation: NYU Langone Health
name: Bibi Sangster
role: PRINCIPAL_INVESTIGATOR
References: